Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary
Bibliographic Data
| ID | 14906352 |
|---|---|
| Authors | Bisola Hamzat (St. Michael's Hospital), Tianru Wang (0000-0002-8221-5720, Institute for Clinical Evaluative Sciences), Ria Garg (0000-0003-3980-4981, St. Michael's Hospital), Anita Iacono (0000-0003-1801-127X, St. Michael's Hospital), Mina Tadrous (0000-0003-1911-6129, Women's College Hospital), Fangyun Wu (Institute for Clinical Evaluative Sciences), Jennifer Wyman (Women's College Hospital), Zoë Dodd (St. Michael's Hospital), S D Pinkerton (University Health Network), Shauna Pinkerton, Ashley Smoke (University Health Network), Thayse Gomes (0000-0002-1468-1965, St. Michael's Hospital, corresponding author), Tara Gomes |
| Year | 2025 |
| Volume | 143 |
| Pages | 104918 |
| Publication date | 2025-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2025.104918 |
| PMID | 40639197 |
| OpenAlex | W4412363186 |
| Language | EN |
| References cited | 16 |
Our findings did not indicate broad treatment destabilization or increased opioid-related toxicity among methadone recipients in the months following the introduction of generic products. Early notification of formulary changes, phased implementation of the policy, as well as information resources developed for patients and clinicians may have played a role in mitigating potential disruptions for this population
Anesthesia · Discontinuation · Environmental health · Family medicine · Formulary · Methadone · Methadone maintenance · Opioid · Population · Psychiatry · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Emergency Medicine · Internal Medicine
Mortality risk during and after opioid substitution treatment
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
Comparing Canadian and United States opioid agonist therapy policies
Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes
Negotiating structural vulnerability following regulatory changes to a provincial methadone program in vancouver, canada
| Citation velocity | historical |
|---|---|
| Highly cited | No |